RETA-10mg
Retatrutide is an investigational peptide-based medication designed primarily for weight loss, obesity treatment, and blood sugar control. It is unique because it activates three hormone receptors at once:
- GLP-1 – reduces appetite and slows stomach emptying.
- GIP – improves insulin response and metabolic function.
- Glucagon – increases energy expenditure and fat burning.
What Retatrutide Is Being Studied For
- Weight loss and obesity
- Type 2 diabetes
- Fatty liver disease (MASLD/NAFLD)
- Sleep apnea related to obesity
- Cardiovascular risk reduction
- Other obesity-related conditions
Potential Benefits
✅ Significant appetite suppression
✅ Increased fullness after meals
✅ Increased calorie and fat burning
✅ Improved blood sugar control
✅ Reduction in visceral (belly) fat
✅ Potential improvements in liver fat and metabolic health
The additional glucagon receptor activity appears to increase energy expenditure and fat oxidation, which may explain why Retatrutide has shown even greater weight-loss results in studies.
Weight Loss Results Seen in Studies
In clinical trials, participants with obesity have achieved average weight losses exceeding 20% of body weight, with some studies reporting around 24–28% average weight loss at higher doses over longer treatment periods.
Common Side Effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Heartburn
- Reduced appetite
- Increased heart rate in some people